Nucleic Acid-Based Multiplex Assays Market

Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as ELISA. Multiplex assays are widely used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others.?
Nucleic Acid-Based Multiplex Assays Market aims to provide a comprehensive presentation of the global market for Nucleic Acid-Based Multiplex Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid-Based Multiplex Assays. Nucleic Acid-Based Multiplex Assays Market contains market size and forecasts of Nucleic Acid-Based Multiplex Assays in global, including the following market information:
Global Nucleic Acid-Based Multiplex Assays Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Nucleic Acid-Based Multiplex Assays market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Reagents & Consumables Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Nucleic Acid-Based Multiplex Assays include Luminex, Thermo Fisher Scientific, Illumina, Bio-Rad Lab, QIAGEN, BD, Abcam, Seegene and Meso Scale Diagnostics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nucleic Acid-Based Multiplex Assays companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nucleic Acid-Based Multiplex Assays Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Nucleic Acid-Based Multiplex Assays Market Segment Percentages, by Type, 2022 (%)
Reagents & Consumables
Instruments & Accessories
Software & Services
Global Nucleic Acid-Based Multiplex Assays Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Nucleic Acid-Based Multiplex Assays Market Segment Percentages, by Application, 2022 (%)
Companion Diagnostics
Research & Development
Clinical Diagnostics
Global Nucleic Acid-Based Multiplex Assays Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Nucleic Acid-Based Multiplex Assays Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nucleic Acid-Based Multiplex Assays revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Nucleic Acid-Based Multiplex Assays revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Luminex
Thermo Fisher Scientific
Illumina
Bio-Rad Lab
QIAGEN
BD
Abcam
Seegene
Meso Scale Diagnostics
Randox Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nucleic Acid-Based Multiplex Assays, market overview.
Chapter 2: Global Nucleic Acid-Based Multiplex Assays market size in revenue.
Chapter 3: Detailed analysis of Nucleic Acid-Based Multiplex Assays company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nucleic Acid-Based Multiplex Assays in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.